Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

280.26
BATS BZX Real-Time Price
As of 12:37pm ET
 -3.35 / -1.18%
Today’s Change
223.02
Today|||52-Week Range
333.65
-1.17%
Year-to-Date
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
9:21am / Zacks.com - Paid Partner Content
Why Forward Pharma A/S Stock Gained 48.2% on Tuesday
Jan 18 / MotleyFool.com - Paid Partner Content
Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
Jan 18 / Zacks.com - Paid Partner Content
Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
Jan 17 / Zacks.com - Paid Partner Content
4 Top Biotech Mutual Funds for 2017
Jan 18 / Zacks.com - Paid Partner Content
Biogen's Multiple Sclerosis Franchise to Drive Growth in 2017
Jan 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and B...
Jan 18 / Zacks.com - Paid Partner Content
Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today
Jan 17 / MotleyFool.com - Paid Partner Content
Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit
Jan 18 / Zacks.com - Paid Partner Content
Forward Pharma Shares Jump on Biogen License Agreement
Jan 17 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close283.61
Today’s open283.77
Day’s range279.80 - 284.09
Volume41,990
Average volume (3 months)1,643,398
Market cap$61.7B
Dividend yield--
Data as of 12:37pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+18.59%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)+8.60%
P/E ratio15.8
Price/Sales7.60
Price/Book6.61

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.67-0.93%
ILMNIllumina Inc-1.38-0.86%
AMGNAmgen-1.85-1.19%
ARIAARIAD Pharmaceutical...-0.00-0.02%
Data as of 12:37pm ET, 01/19/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$4.99
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs